Tacrolimus induces short-term but not long-term clinical response in inflammatory bowel disease.
Iago Rodriguez-LagoJesús Castro-PoceiroAgnès Fernández-ClotetFrancisco MesoneroAntonio López-SanrománAlicia López-GarcíaLucía MárquezAriadna Clos-ParalsFiorella CañeteMiren VicuñaÓscar NantesOlga MerinoVirginia MatallanaJordi GordilloAinara ElorzaRaquel VicenteMaría José CasanovaRocío Ferreiro-IglesiasPablo Pérez-GalindoJosé Manuel BenítezCarlos TaxoneraMaría José GarcíaEduardo MartínUrko AguirreFrancisco Javier García-Alonsonull nullPublished in: Alimentary pharmacology & therapeutics (2020)
Tacrolimus shows a clinical benefit in both CD and UC after 3 months of treatment, but its long-term effectiveness and frequent adverse events remain relevant issues in clinical practice.